This Protocol is applicable to Class 1, 2, and Class 3 applicants. Resting ECG shall be performed at the following intervals:

Similar documents
2003 World Health Organization (WHO) / International Society of Hypertension (ISH) Statement on Management of Hypertension.

Chronic Benefit Application Form Cardiovascular Disease and Diabetes

CHALLENGES OF HYPERTENSION IN THE COALFACE

Management of Hypertension

Serum levels of galectin-1, galectin-3, and galectin-9 are associated with large artery atherosclerotic

Depok-Indonesia STEPS Survey 2003

Summary of recommendations

Adult Pre Participation Screening and Exercise Prescription Practicum

Chapter 08. Health Screening and Risk Classification

Appendix This appendix was part of the submitted manuscript and has been peer reviewed. It is posted as supplied by the authors.

Cardiac Pathophysiology

hypertension Head of prevention and control of CVD disease office Ministry of heath

Screening Results. Juniata College. Juniata College. Screening Results. October 11, October 12, 2016

Test5, Here is Your My5 to Health Profile with Metabolic Syndrome Insight

ASSeSSing the risk of fatal cardiovascular disease

Approach to patient with hypertension. Dr. Amitesh Aggarwal

TIP. Documentation and coding guide. Disease definitions* Prevalence and statistics associated with HTN**

High intensity exercise improves cardiac structure and function and reduces liver fat in adults with Type 2 diabetes

Section 03: Pre Exercise Evaluations and Risk Factor Assessment

Know Your Number Aggregate Report Single Analysis Compared to National Averages

Metabolic Syndrome.

Personal Diabetes Passport

Cardiovascular Risk Assessment and Management Making a Difference

Total risk management of Cardiovascular diseases Nobuhiro Yamada

ABPM screen 300/400 Risk Assessment

surtout qui n est PAS à risque?

How Low Do We Go? Update on Hypertension

NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE General practice Indicators for the NICE menu

VA/DoD Clinical Practice Guideline for the Diagnosis and Management of Hypertension - Pocket Guide Update 2004 Revision July 2005

Your health is a crucial aspect of your life. That s why the Yakima Heart Center offers this booklet; to help you identify the numbers that affect

CVD Prevention, Who to Consider

PRESENTED BY BECKY BLAAUW OCT 2011

Lecture 8 Cardiovascular Health Lecture 8 1. Introduction 2. Cardiovascular Health 3. Stroke 4. Contributing Factors

ANTI- HYPERTENSIVE AGENTS

New Hypertension Guideline Recommendations for Adults July 7, :45-9:30am

Elevation of Serum Creatinine: When to Screen, When to Refer. Bruce F. Culleton, MD, FRCPC; and Jolanta Karpinski, MD, FRCPC

Antihypertensive Trial Design ALLHAT

Module 2. Global Cardiovascular Risk Assessment and Reduction in Women with Hypertension

5.2 Key priorities for implementation

CARDIOVASCULAR RISK FACTORS & TARGET ORGAN DAMAGE IN GREEK HYPERTENSIVES

Mississippi Stroke Systems of Care

7/6/2012. University Pharmacy 5254 Anthony Wayne Drive Detroit, MI (313)

Understanding Cholesterol and Triglycerides

PFIZER INC. THERAPEUTIC AREA AND FDA APPROVED INDICATIONS: See USPI.

Case Study: Chris Arden. Peripheral Arterial Disease

AUTONOMIC FUNCTION IS A HIGH PRIORITY

Medical Surveillance on the Staff of UiTM Pahang

From the desk of the: THE VIRTUAL NEPHROLOGIST

Patient Encounters in the Primary Care Setting

Hypertension Clinical case scenarios for primary care

Metabolic Syndrome. Shon Meek MD, PhD Mayo Clinic Florida Endocrinology

Risk Factors for Heart Disease

Know Your Numbers. Your guide to maintaining good health. Helpful information from Providence Medical Center and Saint John Hospital

Figure S1. Comparison of fasting plasma lipoprotein levels between males (n=108) and females (n=130). Box plots represent the quartiles distribution

Supplementary Appendix

SUMMARY OF CHANGES TO QOF 2017/18 - ENGLAND CLINICAL

4/4/17 HYPERTENSION TARGETS: WHAT DO WE DO NOW? SET THE STAGE BP IN CLINICAL TRIALS?

Diabetes Mellitus: A Cardiovascular Disease

17/18 Threshold 18/19 Points 18/19. Points NO CHANGE NO CHANGE NO CHANGE

Yuqing Zhang, M.D., FESC Department of Cardiology, Fu Wai Hospital. CAMS & PUMC, Beijing, China

Individual Study Table Referring to Item of the Submission: Volume: Page:

HSN301 REVISION NOTES TOPIC 1 METABOLIC SYNDROME

Metabolic Syndrome and Chronic Kidney Disease

ΑΡΥΙΚΗ ΠΡΟΔΓΓΙΗ ΤΠΔΡΣΑΙΚΟΤ ΑΘΔΝΟΤ. Μ.Β.Παπαβαζιλείοσ Καρδιολόγος FESC - Γιεσθύνηρια ιζμανόγλειον ΓΝΑ Clinical Hypertension Specialist ESH

Blood Pressure 1 of 22 Boardworks Ltd 2011

Relationship between cardiovascular risk factors and traditional Chinese constitution in subjects with high-normal blood pressure

Hulst, Rehda Abedalmonem, Stephanie Rush, Dr A Elkrail.

Andrejs Kalvelis 1, MD, PhD, Inga Stukena 2, MD, Guntis Bahs 3 MD, PhD & Aivars Lejnieks 4, MD, PhD ABSTRACT INTRODUCTION. Riga Stradins University

10/8/2018. Lecture 9. Cardiovascular Health. Lecture Heart 2. Cardiovascular Health 3. Stroke 4. Contributing Factor

National Collaborative Wave 2 (Wave 9): National Diabetes Prevention and Management Wave, Month 9 Diabetes Management: Diabetes Register

2013 Hypertension Measure Group Patient Visit Form

INTRODUCTORY TEXT BOX

(n=6279). Continuous variables are reported as mean with 95% confidence interval and T1 T2 T3. Number of subjects

Blood Pressure Acre Surgery Diviash Thakrar

Hypertension AN OVERVIEW

Your Numbers Tell Your Story. Jennifer Stafford, RN Legacy Meridian Park Medical Center

14/15 Threshold 15/16 Points 15/16. Points. Retired Replaced by NM82/AF007. Replacement NO CHANGE

Statistical Fact Sheet Populations

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process

AF Diagnosis. Incorporated into over 75 health checks and Public Health Checks

Q&A. DEMO Version

Each student should record the ECG of one of the members of the lab group and have their own ECG recorded.

Clinical Practice Guideline Key Points

MPharmProgramme. Hypertension (HTN)

Presentation of hypertensive emergency

S150 KEEP Analytical Methods. American Journal of Kidney Diseases, Vol 55, No 3, Suppl 2, 2010:pp S150-S153

EXS 145 Guidelines for Exercise Testing & Prescription

GENERAL SAFETY INDUCTION INFORMATION SCHOOL OF HEALTH SCIENCES EXERCISE SCIENCE LABORATORIES (G127/C003/EXERCISE CLINIC)

Know Your Number Aggregate Report Comparison Analysis Between Baseline & Follow-up

Cardiovascular Diseases in CKD

Original Research Article

Implications of The LookAHEAD Trial: Is Weight Loss Beneficial for Patients with Diabetes?

A factorial randomized trial of blood pressure lowering and intensive glucose control in 11,140 patients with type 2 diabetes

OBESITY IN PRIMARY CARE

Report Operation Heart to Heart

The Effects of Moderate Intensity Exercise on Lipoprotein-Lipid Profiles of Haramaya University Community

CVD Risk Assessment. Michal Vrablík Charles University, Prague Czech Republic

High Risk OSA n = 5,359

Guest Speaker Evaluations Viewer Call-In Thanks to our Sponsors: Phone: Fax: Public Health Live T 2 B 2

Long-Term Complications of Diabetes Mellitus Macrovascular Complication

Transcription:

SCHEDULE 34: PROTOCOL ON ELECTROCARDIOGRAMS ( ECG ) 1. Applicability This Protocol is applicable to Class 1, 2, and Class 3 applicants. 2. Resting ECG Resting ECG shall be perfmed at the following intervals: (1) Class 1 (a) at initial medical examination; (b) every 2 years between the age of thirty (30) and fifty (50); (c) annually after the age of fifty (50). (2) Class 2 (a) at initial medical examination; (b) first exam after the age of 40 (c) every 2 years after the age of fifty (50). (3) Class 3 (a) at initial medical examination; (b) every 2 years after the age of fifty (50). 3. Procedure f Resting ECG (1) A resting ECG shall be recded with the subject at rest in a warm environment. (2) The skin should be prepared with spirit abrasive, both. (3) Resting ECG is perfmed using a 12-lead standard ECG machine and chest leads should be placed accurately. (4) Leads V1 and V2 should be placed in the fourth inter-costal spaces on either side of the sternum. (5) Lead V4 is placed at the position of the apex of the nmal heart the fifth inter-costal space in the mid-clavicular line. (6) Lead V3 is placed midway between V2 and V4. Leads V5 and V6 are placed at the same level as V4 in the anteri and mid-axillary lines, respectively. 1

(7) The limb leads are placed on the right and left arms, and the right and left legs respectively. 4. Interpretation (1) All ECGs are to be interpreted by a DAME trained in ECG reading who would refer to a cardiologist specialist physician when in doubt. 5. Stress ECG 5.1 Indications f stress ECG (1) Stress ECG shall be perfmed in the following circumstances: (a) (b) (c) (d) Any abnmal resting ECG; The following indications should be considered in determining the necessity of a stress ECG: Hypertension, Smoking, Dyslipidaemia, Diabetes Mellitus, Raised BMI, waist circumference/abdominal obesity, family histy of early onset of cardiovascular disease. In accdance with the cardiovascular assessment algithm: f all applicants classified as Moderate, High Very High in accdance with the algithm; Provided that: (i) Stress ECG f moderate applicants may be perfmed by a DAME (ii) Stress ECG f High Very High applicants shall only be perfmed by a cardiologist a specialist physician. 6. Cardiovascular assessment (1) Cardiovascular assessment shall be done based on the South African Hypertension Guidelines. Cardiovascular assessment shall be done in accdance with the tables below. TABLE 1 MAJOR RISK FACTORS, TARGET ORGAN DAMAGE, AND ASSOCIATED CLINICAL CONDITIONS 2

MAJOR RISK FACTORS TARGET ORGAN DAMAGE ASSOCIATED CLINICAL CONDITIONS Levels of systolic and diastolic Left ventricular hypertrophy: Conary heart disease BP based on ECG Smoking Microalbuminuria: albumin/ Heart failure creatinine ratio 3 30 mg/mmol Dyslipidaemia Slightly elevated creatinine Chronic kidney disease: Total cholesterol >6.5 mmol/l, Men 115 133 μmol/l albumin OR creatinine ratio >30 Women 107 124 μmol/l creatinine ratio >30 mg/mmol mg/mmol LDL >4 mmol/l, OR HDL men <1 and women <1.2 mmol/l Diabetes mellitus Men >55 years Women >65 years Family histy of early onset of: cardiovascular disease Men aged <55 years Women aged <65 years Waist circumference abdominal obesity Men 102 cm Women 88 cm The exceptions are South Asians and Chinese: men >90 cm and women >80 cm Stroke transient ischaemic attack Peripheral arterial disease Advanced retinopathy Haemrhages OR Exudates Papilloedema TABLE 2 Stratification of to quantify prognosis Other BP (mmhg) facts Nmal High-nmal Stage 1 and disease SBP 120 SBP 130 139 Mild histy 129 DBP 85 89 hypertension SBP 140 159 Stage 2 Moderate hypertension SBP 160 179 Stage 3 Severe hypertension SBP >180 3

DBP 80 84 DBP 90 99 DBP 100 109 DBP >110 No other maj Average Average Low added Moderate added High added facts 1 2 maj Low added Low added Moderate Moderate added Very high facts added added 3maj Moderate High added High added High added Very high facts target-gan damage added added diabetes mellitus Associated Very high Very high Very high Very high added Very high clinical conditions added added added added * Legend Average Risk and Low Added Risk Bloods (Fasting Glucose, Fasting Lipogram, U&E-including Creatinine) Resting ECG: less than the age of 40 years Stress ECG: 40 years of age and above (to be done by a DAME) Moderate Added Risk Annual Stress ECG (done by a DAME-Designated Medical Examiner) Annual Bloods (U&E including Creatinine, Fasting Glucose, Fasting Lipo-gram) f all Classes Applicable Protocol f Co-mbidity 4

High Added Risk Stress ECG (to be done by a Cardiologist minimum stress level should be 85%) Annual Bloods (U&E including Creatinine, Fasting Glucose, Fasting Lipo-gram) Applicable Protocol f Co-mbidity Very High Added Risk Stress ECG (to be done by a Cardiologist minimum stress level should be 85%) Annual Bloods (U&E including Creatinine, Fasting Glucose, Fasting Lipo-gram) Applicable Protocol f Co-mbidity 7. Procedure f Stress ECG (1) Stress ECG is perfmed using a 12-lead standard ECG machine displaying at least 3 leads simultaneously and optimally filtered and damped. The leads should be placed as f a standard resting ECG except the limb leads are positioned on the shoulders and the iliac crests on each side. (2) Recdings should be made at rest in the erect and supine positions, and after hyperventilation f 10 seconds. The subject should be exercised to 85% of maximal heart rate symptom limitation, whichever comes first, and be expected to complete at least 3 stages (nine minutes) of the Bruce Protocol achieve an Oxygen uptake equivalent to 11 metabolic equivalents (METs). The age-predicted maximum heart rate is calculated by subtracting the age in years from 220 beats per minute (bpm). The test is most sensitive when taken to symptom limitation rather than any percentage of the age-predicted maximum. If exercise needs to be terminated due to symptom development, license holder should be referred to a cardiologist (if stress is perfmed by DAME). The reason f discontinuing the test should be recded together with the presence absence of any symptom. (3) Immediately post-stress, while the license holder is in the upright position, twelve (12) second recdings should be made at the following intervals: 0, 3, 5 and 7 minutes. If there is any indication, recdings can be taken at two (2) minute intervals up to 11 minutes. Any abnmalities on stress ECG shall be referred to a cardiologist, if the stress ECG is perfmed by a DAME. 5

(4) A standardized protocol such as the Bruce treadmill protocol 3 equivalent should be employed. The Bruce protocol is not the only one available but it is the most widely used. 8. Intervals (1) Stress ECG shall be perfmed in accdance with the cardiovascular assessment algithm. (2) Applicants classified as Moderate, High Very High shall have an annual stress- ECG (if some positive actions are taken to reduce mitigate the of those classified as moderate, an annual stress-ecg is probably not necessary, assuming the first one was negative). 6